Real-World Insights

Fireside Chat with Debiopharm: Using real-world genomic data to support drug and biomarker development

June 16, 2020
During this interactive webcast, the QIAGEN Real-World Insights team will interview Dr. Anna Pokorska-Bocci, PhD, Associate Principal Scientist in Personalized Medicine at Debiopharm International.

Dr. Pokorska-Bocci will discuss the challenges around developing an oncology targeted therapy and evaluating biomarkers that predict drug sensitivity. She will share her experience working with QIAGEN's Real-World Insights team and how the customized analyses and offerings provided have enabled Debiopharm to accelerate drug development. Attendees will also have the opportunity to ask questions and talk with Dr. Anna Pokorska-Bocci about her work.

QIAGEN Real-World Insights

Whether searching for clinically applicable biomarkers, designing a new companion diagnostic (CDx), or honing your study accrual and go-to-market strategies, QIAGEN Real-World Insights combines robust real-world genomic data from over 300,000 cancer cases and advanced analytics to shorten development timelines, optimize study designs, and improve patient outcomes. 

Click here to learn more.

Related videos

Real-World Insights

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

196 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...

Real-World Insights

Using Real World Clinical NGS Data for Precision Oncology

230 views March 15, 2021

Next generation sequencing (NGS) has become a routine component in oncology...